Subscribe to RSS

DOI: 10.1055/a-2666-6277
ANGWC Nomogram for Predicting Poor 3-month Outcome after Intravenous Thrombolysis in Young and Middle-aged Patients with First-ever Stroke
Funding This work was supported by the National Natural Science Foundation of China (U24A20686), Science and Technology Department of Jilin Province (YDZJ202302CXJD061, 20220303002SF), and Jilin Provincial Key Laboratory (YDZJ202302CXJD017) to Y.Y., the Talent Reserve Program of the First Hospital of Jilin University (JDYYCB-2023002) to Z.G., and the Graduate Innovation Fund of Jilin University (2025CX292) to S.L.

Abstract
Background
The rising prevalence of ischemic stroke among younger individuals is concerning. Despite the significant benefits of intravenous thrombolytic therapy for young and middle-aged patients, the disease burden in this demographic is often overshadowed by that of older patient groups. This study aims to identify the risk factors for poor 3-month outcomes following intravenous thrombolysis in young and middle-aged patients with first-ever stroke and to develop a novel nomogram.
Methods
This prospective study included patients aged 18 to 59 years with a first ischemic stroke from 16 hospitals. Patients from one of the hospitals were designated as the training cohort. General information and clinical data were compared between the favorable outcome (modified Rankin Scale [mRS] score < 2) and the poor outcome groups (mRS score ≥ 2). Logistic regression analysis was used to develop the nomogram. An additional 113 patients from the other 15 hospitals were recruited as the validation cohort.
Results
A total of 217 patients were enrolled in the training cohort, with 47% experiencing poor 3-month outcomes. Five variables were selected to construct the ANGWC (Age, NIHSS score, blood Glucose, White blood cell count, and total Cholesterol) nomogram. The AUC of the nomogram was 0.802 in the training cohort and 0.747 in the validation cohort. The Hosmer–Lemeshow goodness-of-fit test showed a P-value > 0.05, and calibration curve slopes were close to 1. Decision curve analysis indicated good clinical utility.
Conclusion
The ANGWC nomogram provides a reliable prediction of poor 3-month outcomes after intravenous thrombolysis in young and middle-aged patients with first-ever stroke.
Keywords
ischemic stroke - intravenous thrombolysis - young and middle-aged - nomogram - predictive modelData Availability Statement
Data will be made available from the corresponding author upon reasonable request.
Authors' Contribution
Z.G., Y.Y., H.J., and S.L. conceived this study. Y.Q. and R.A. collected data. J.R. and P.Z. provided research materials and methods. S.L. and Y.Q. analyzed the data. S.L., Y.-Q.Y., Z.S., and J.L. drafted the manuscript. All authors of the manuscript have reviewed and approved the final version of the manuscript.
* These authors contributed equally to this work.
Publication History
Received: 07 February 2025
Accepted: 18 July 2025
Article published online:
11 August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024; 23 (04) 344-381
- 2 Béjot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med 2016; 45 (12 Pt 2): e391-e398
- 3 GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20 (10) 795-820
- 4 Ekker MS, Boot EM, Singhal AB. et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol 2018; 17 (09) 790-801
- 5 Khan SU, Khan MZ, Khan MU. et al. Clinical and economic burden of stroke among young, midlife, and older adults in the United States, 2002-2017. Mayo Clin Proc Innov Qual Outcomes 2021; 5 (02) 431-441
- 6 Dodds JA, Xian Y, Sheng S. et al. Thrombolysis in young adults with stroke: findings from Get With The Guidelines-Stroke. Neurology 2019; 92 (24) e2784-e2792
- 7 Kim J, Kim JY, Kang J. et al. Improvement in delivery of ischemic stroke treatments but stagnation of clinical outcomes in young adults in South Korea. Stroke 2023; 54 (12) 3002-3011
- 8 Jacob MA, Ekker MS, Allach Y. et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults—a worldwide meta-analysis: the GOAL Initiative. Neurology 2022; 98 (06) e573-e588
- 9 Huang P, Yi X. Risk factors and a model for prognosis prediction after intravenous thrombolysis with alteplase in acute ischemic stroke based on propensity score matching. Int J Immunopathol Pharmacol 2024; 38: 3946320241274231
- 10 Nisar T, Hanumanthu R, Khandelwal P. Symptomatic intracerebral hemorrhage after intravenous thrombolysis: predictive factors and validation of prediction models. J Stroke Cerebrovasc Dis 2019; 28 (11) 104360
- 11 Ping Z, Huiyu S, Min L, Qingke B, Qiuyun L, Xu C. Explainable machine learning for long-term outcome prediction in two-center stroke patients after intravenous thrombolysis. Front Neurosci 2023; 17: 1146197
- 12 Shariat SF, Capitanio U, Jeldres C, Karakiewicz PI. Can nomograms be superior to other prediction tools?. BJU Int 2009; 103 (04) 492-495 , discussion 495–497
- 13 Cappellari M, Turcato G, Forlivesi S. et al. The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke. Int J Stroke 2018; 13 (07) 700-706
- 14 Cappellari M, Turcato G, Forlivesi S. et al. STARTING-SICH nomogram to predict symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke. Stroke 2018; 49 (02) 397-404
- 15 Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin scale and its use in future stroke trials. Stroke 2017; 48 (07) 2007-2012
- 16 Bluhmki E, Danays T, Biegert G, Hacke W, Lees KR. Alteplase for acute ischemic stroke in patients aged >80 years: pooled analyses of individual patient data. Stroke 2020; 51 (08) 2322-2331
- 17 Cai W, Zhang K, Li P. et al. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect. Ageing Res Rev 2017; 34: 77-87
- 18 Berge E, Whiteley W, Audebert H. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 2021; 6 (01) I-LXII
- 19 Monsour M, Borlongan CV. The central role of peripheral inflammation in ischemic stroke. J Cereb Blood Flow Metab 2023; 43 (05) 622-641
- 20 Chen J, Zhang Z, Chen L. et al. Correlation of changes in leukocytes levels 24 hours after intravenous thrombolysis with prognosis in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2018; 27 (10) 2857-2862
- 21 Barow E, Quandt F, Cheng B. et al. Association of white blood cell count with clinical outcome independent of treatment with alteplase in acute ischemic stroke. Front Neurol 2022; 13: 877367
- 22 Maestrini I, Strbian D, Gautier S. et al. Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes. Neurology 2015; 85 (16) 1408-1416
- 23 Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation 2019; 16 (01) 142
- 24 Tsivgoulis G, Katsanos AH, Mavridis D. et al. Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score-matched analysis from the SITS-ISTR registry. Diabetes 2019; 68 (09) 1861-1869
- 25 Wang Y, Jiang G, Zhang J, Wang J, You W, Zhu J. Blood glucose level affects prognosis of patients who received intravenous thrombolysis after acute ischemic stroke? A meta-analysis. Front Endocrinol (Lausanne) 2023; 14: 1120779
- 26 Williams LS, Rotich J, Qi R. et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59 (01) 67-71
- 27 Ferrari F, Moretti A, Villa RF. Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity. Neural Regen Res 2022; 17 (02) 292-299
- 28 Xia C, Wang X, Lindley RI. et al; ENCHANTED Investigators. Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: the ENCHANTED trial. Clin Neurol Neurosurg 2020; 198: 106254
- 29 Escudero-Martínez I, Thorén M, Matusevicius M. et al. Association of cholesterol levels with hemorrhagic transformation and cerebral edema after reperfusion therapies. Eur Stroke J 2023; 8 (01) 294-300
- 30 Lin SF, Chao AC, Hu HH. et al; Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group. Low cholesterol levels increase symptomatic intracranial hemorrhage rates after intravenous thrombolysis: a multicenter cohort validation study. J Atheroscler Thromb 2019; 26 (06) 513-527
- 31 Lv S, Song Y, Zhang FL. et al. Early prediction of the 3-month outcome for individual acute ischemic stroke patients who received intravenous thrombolysis using the N2H3 nomogram model. Ther Adv Neurol Disord 2020; 13: 1756286420953054
- 32 Niu L, Jiang SW, Wang Y. et al. Total cholesterol affects the outcome of patients with anterior cerebral artery-occluded acute ischemic stroke treated with thrombolysis. Eur Rev Med Pharmacol Sci 2020; 24 (03) 1504-1514
- 33 Ping Z, Min L, Qiuyun L, Xu C, Qingke B. Prognostic nomogram for the outcomes in acute stroke patients with intravenous thrombolysis. Front Neurosci 2022; 16: 1017883
- 34 Takaoka M, Zhao X, Lim HY. et al. Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis. Nature 2024; 634 (8033): 457-465
- 35 Kaneko H, Itoh H, Kiriyama H. et al. Lipid profile and subsequent cardiovascular disease among young adults aged < 50 years. Am J Cardiol 2021; 142: 59-65
- 36 Lee H, Park JB, Hwang IC. et al. Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: a nationwide cohort study. Eur J Prev Cardiol 2020; 27 (08) 870-881
- 37 Yuan K, Chen J, Xu P. et al. A nomogram for predicting stroke recurrence among young adults. Stroke 2020; 51 (06) 1865-1867
- 38 Mbarek L, Chen S, Jin A. et al. Predicting 3-month poor functional outcomes of acute ischemic stroke in young patients using machine learning. Eur J Med Res 2024; 29 (01) 494
- 39 Jin H, Peng Q, Li M. et al. Supra-Blan2 t score as a multisystem-based risk score to predict poor 3-month outcome in acute ischemic stroke patients with intravenous thrombolysis. CNS Neurosci Ther 2024; 30 (02) e14381
- 40 Zhang XX, Yao FR, Zhu JH. et al. Nomogram to predict haemorrhagic transformation after stroke thrombolysis: a combined brain imaging and clinical study. Clin Radiol 2022; 77 (01) e92-e98
- 41 Cooray C, Mazya M, Bottai M. et al. External validation of the ASTRAL and DRAGON scores for prediction of functional outcome in stroke. Stroke 2016; 47 (06) 1493-1499
- 42 Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using age and NIH Stroke Scale: SPAN-100. Neurology 2013; 80 (01) 21-28
- 43 Ning X, Sun J, Jiang R. et al. Increased stroke burdens among the low-income young and middle aged in rural China. Stroke 2017; 48 (01) 77-83
- 44 Wang Y, Liu J, Wang W. et al. Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study. J Hypertens 2016; 34 (12) 2434-2440
- 45 Saeed S, Gerdts E, Waje-Andreassen U. et al. Left ventricular myocardial dysfunction in young and middle-aged ischemic stroke patients: the Norwegian stroke in the young study. J Hypertens 2019; 37 (03) 538-545
- 46 Zheng Z, Song R, Zhao Y, Lv H, Wang Y, Yu C. An investigation of the level of stigma and the factors influencing it in the rehabilitation of young and middle-aged stroke patients—a cross-sectional study. BMC Neurol 2023; 23 (01) 139
- 47 Xu L, Dong Q, Jin A. et al. Experience of financial toxicity and coping strategies in young and middle-aged patients with stroke: a qualitative study. BMC Health Serv Res 2024; 24 (01) 94